China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Cash & Equivalents	11.47	17.37	15.57	13.36	7.29	9.29
Short-Term Investments	0	0	1.62	1.58	1.59	0.08
Cash & Cash Equivalents	11.47	17.37	17.19	14.94	8.87	9.37
Cash Growth	611.09%	1.06%	15.03%	68.39%	-5.34%	875.21%
Receivables	1.4	1.39	3.38	5.03	4.74	4.5
Inventory	0.49	0.53	1.02	0.86	0.89	1.01
Other Current Assets	0.14	0.23	0.86	2.41	5.13	0.71
Total Current Assets	13.5	19.52	22.45	23.23	19.64	15.59
Property, Plant & Equipment	1.07	1.27	1.59	1.79	1.9	1.81
Goodwill and Intangibles	0.02	0.03	0.04	0.05	0.05	0.06
Other Long-Term Assets	0	8.74	9.46	9.48	0.11	0.01
Total Long-Term Assets	1.09	10.03	11.09	11.31	2.07	1.88
Total Assets	14.59	29.55	33.55	34.55	21.7	17.47
Accounts Payable	1.32	1.38	1.48	1.46	1.94	1.69
Current Debt	2.84	3.39	2.05	0.04	6.69	0.26
Other Current Liabilities	5.04	9.73	13.59	17.09	3.64	4.37
Total Current Liabilities	9.2	14.5	17.12	18.58	12.26	6.32
Long-Term Debt	0.31	0.37	0	0.01	0.04	0.04
Total Long-Term Liabilities	0.31	0.37	0	0.01	0.04	0.04
Total Liabilities	9.51	14.86	17.12	18.59	12.3	6.36
Total Debt	3.15	3.76	2.05	0.04	6.72	0.3
Debt Growth	13005.71%	83.58%	4613.57%	-99.35%	2120.13%	-21.36%
Retained Earnings	-31.31	-21.61	-15.69	-9.95	-7.2	3.08
Comprehensive Income	-1.02	-0.2	0.96	0.53	-0.59	0.05
Shareholders' Equity	5.08	14.69	16.42	15.96	9.4	11.11
Net Cash / Debt	8.31	13.61	15.14	14.9	2.15	9.07
Net Cash / Debt Growth	423.47%	-10.09%	1.63%	593.38%	-76.31%	1474.64%
Net Cash Per Share	16.58	50.99	364.02	517.57	173.76	881.99
Working Capital	4.3	5.02	5.33	4.65	7.37	9.27
Book Value Per Share	10.12	55.03	394.91	554.56	760.36	1080.07

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).